Npas4 Is a Novel Activity–Regulated Cytoprotective Factor in Pancreatic β-Cells

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

FIG. 5.
FIG. 5.

Npas4 overexpression inhibits β-cell responsiveness to the GLP-1 receptor agonist exendin-4. MIN6 cells were transduced with control (Ad-Cerulean, white bars) or Npas4 (Ad-Npas4, black bars) adenovirus and then cultured for 48 h. No statistical difference was observed in glucose-stimulated insulin secretion in either MIN6 cells (n = 3–5) (A) or islets (n = 5–6) (B). However, exendin-4–potentiated insulin secretion was reduced after Ad-Npas4 transduction in both MIN6 cells (A) and mouse pancreatic islets (B). Npas4 overexpression diminished exendin-4–stimulated cAMP production in MIN6, significantly reducing maximal stimulation as well as shifting the EC50 from 0.76 to 2.65 nmol/L (n = 3) (C). Significance was determined using two-tailed Student t tests or a one-way ANOVA with Dunnett post hoc analysis where applicable. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001.

This Article

  1. Diabetes vol. 62 no. 8 2808-2820